Ypsomed Holding (YPHD.F) Stock Overview
Develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
YPHD.F Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Ypsomed Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 475.18 |
| 52 Week High | CHF 535.75 |
| 52 Week Low | CHF 362.28 |
| Beta | 1.15 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 6.61% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 594.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| YPHD.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | 0.5% |
| 1Y | 6.6% | -0.8% | 20.1% |
Return vs Industry: YPHD.F exceeded the US Medical Equipment industry which returned -0.9% over the past year.
Return vs Market: YPHD.F underperformed the US Market which returned 20% over the past year.
Price Volatility
| YPHD.F volatility | |
|---|---|
| YPHD.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: YPHD.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine YPHD.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 2,644 | Simon Michel | www.ypsomed.com |
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices.
Ypsomed Holding AG Fundamentals Summary
| YPHD.F fundamental statistics | |
|---|---|
| Market cap | US$5.34b |
| Earnings (TTM) | US$108.75m |
| Revenue (TTM) | US$930.67m |
Is YPHD.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YPHD.F income statement (TTM) | |
|---|---|
| Revenue | CHF 748.87m |
| Cost of Revenue | CHF 456.80m |
| Gross Profit | CHF 292.07m |
| Other Expenses | CHF 204.56m |
| Earnings | CHF 87.50m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Nov 12, 2025
| Earnings per share (EPS) | 6.41 |
| Gross Margin | 39.00% |
| Net Profit Margin | 11.68% |
| Debt/Equity Ratio | 39.3% |
How did YPHD.F perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/01 09:34 |
| End of Day Share Price | 2025/08/06 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ypsomed Holding AG is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gaurav Jain | Barclays |
| Pallav Mittal | Barclays |
| Curtis Moiles | BNP Paribas |